PET/MRI in Oncological Imaging: State of the Art

Positron emission tomography (PET) combined with magnetic resonance imaging (MRI) is a hybrid technology which has recently gained interest as a potential cancer imaging tool. Compared with CT, MRI is advantageous due to its lack of ionizing radiation, superior soft-tissue contrast resolution, and wider range of acquisition sequences. Several studies have shown PET/MRI to be equivalent to PET/CT in most oncological applications, possibly superior in certain body parts, e.g., head and neck, pelvis, and in certain situations, e.g., cancer recurrence. This review will update the readers on recent advances in PET/MRI technology and review key literature, while highlighting the strengths and weaknesses of PET/MRI in cancer imaging.

[1]  Jurgen J Fütterer,et al.  Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. , 2014, AJR. American journal of roentgenology.

[2]  P. Heusch,et al.  Thoracic Staging in Lung Cancer: Prospective Comparison of 18F-FDG PET/MR Imaging and 18F-FDG PET/CT , 2014, The Journal of Nuclear Medicine.

[3]  Felix Nensa,et al.  Whole-body [18F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results , 2014, European Radiology.

[4]  Longjiang Li,et al.  Magnetic Resonance Imaging for Diagnosis of Mandibular Involvement from Head and Neck Cancers: A Systematic Review and Meta-Analysis , 2014, PloS one.

[5]  J. Stoker,et al.  Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. , 2010, Radiology.

[6]  S E Harms,et al.  MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. , 1993, Radiology.

[7]  S. Cherry,et al.  Simultaneous PET and MR imaging , 1997, Physics in medicine and biology.

[8]  Christian Rubbert,et al.  Artifacts and diagnostic pitfalls in positron emission tomography-magnetic resonance imaging. , 2014, Seminars in roentgenology.

[9]  J. L. Vercher-Conejero,et al.  N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm: Initial experience , 2013, European Radiology.

[10]  Ken Kodama,et al.  Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study. , 2011, Lung cancer.

[11]  M. Meyerand,et al.  Intrinsically Germanium‐69‐Labeled Iron Oxide Nanoparticles: Synthesis and In‐Vivo Dual‐Modality PET/MR Imaging , 2014, Advanced materials.

[12]  M. Forsting,et al.  [18F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  K. Kang,et al.  Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study. , 2005, European journal of cancer.

[14]  D. Farina,et al.  Diagnostic accuracy of magnetic resonance imaging in the assessment of mandibular involvement in oral-oropharyngeal squamous cell carcinoma: a prospective study. , 2004, Archives of otolaryngology--head & neck surgery.

[15]  Craig S. Levin,et al.  Prototype time-of-flight PET ring integrated with a 3T MRI system for simultaneous whole-body PET/MR imaging , 2013 .

[16]  I. Steffen,et al.  Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours , 2012, European Radiology.

[17]  C. Claussen,et al.  Simultaneous Mr/pet Imaging of the Human Brain: Feasibility Study 1 , 2022 .

[18]  Markus Schwaiger,et al.  Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology , 2012, The Journal of Nuclear Medicine.

[19]  J. Han,et al.  Preoperative Staging of Uterine Cervical Carcinoma: Comparison of CT and MRI in 99 Patients , 1993, Journal of computer assisted tomography.

[20]  Patrick Veit-Haibach,et al.  Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  D. Owens,et al.  Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with NonSmall-Cell Lung Cancer , 2003, Annals of Internal Medicine.

[22]  Paul Vaska,et al.  Small animal simultaneous PET/MRI: initial experiences in a 9.4 T microMRI , 2011, Physics in medicine and biology.

[23]  Elizabeth A Morris,et al.  MRI of occult breast carcinoma in a high-risk population. , 2003, AJR. American journal of roentgenology.

[24]  P. Silverman,et al.  Diagnosis, staging, and surveillance of cervical carcinoma. , 2003, AJR. American journal of roentgenology.

[25]  J. van den Hoff,et al.  FDG PET/MR for the assessment of lymph node involvement in lymphoma: initial results and role of diffusion-weighted MR. , 2014, Academic radiology.

[26]  T. Yen,et al.  Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Tobias Schaeffter,et al.  Performance Evaluation of an MRI-Compatible Pre-Clinical PET System Using Long Optical Fibers , 2010, IEEE Transactions on Nuclear Science.

[28]  A. Ahmadian,et al.  MRI-guided attenuation correction in whole-body PET/MR: assessment of the effect of bone attenuation , 2013, Annals of Nuclear Medicine.

[29]  Patrick Veit-Haibach,et al.  Workflow Considerations in PET/MR Imaging , 2014, The Journal of Nuclear Medicine.

[30]  Douglas K Owens,et al.  Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. , 2003, Annals of internal medicine.

[31]  Wei-Che Lin,et al.  A Comparative Study of Fused FDG PET/MRI, PET/CT, MRI, and CT Imaging for Assessing Surrounding Tissue Invasion of Advanced Buccal Squamous Cell Carcinoma , 2011, Clinical nuclear medicine.

[32]  Robert E Lenkinski,et al.  Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. , 2007, Radiology.

[33]  B. I. Choi,et al.  Uterine cervical carcinoma: comparison of CT and MR findings. , 1990, Radiology.

[34]  A Heinig,et al.  Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. , 1997, European journal of radiology.

[35]  O Lucidarme,et al.  Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. , 1994, Radiology.

[36]  Habib Zaidi,et al.  Clinical Applications of Hybrid PET/MRI in Neuroimaging , 2013, Clinical nuclear medicine.

[37]  M. Kattan,et al.  Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.

[38]  Heinrich R Schelbert,et al.  Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  K. Sugimura,et al.  Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor: comparison with 18F-FDG contrast-enhanced PET/CT and pelvic MRI , 2013, Annals of Nuclear Medicine.

[40]  A. Lammertsma,et al.  Determinants of Diagnostic Performance Of [F-18]Fluorodeoxyglucose Positron Emission Tomography for Axillary Staging in Breast Cancer , 2002, Annals of surgery.

[41]  G. Delso,et al.  PET/MRI system design , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[42]  A. Drzezga,et al.  First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses , 2012, The Journal of Nuclear Medicine.

[43]  Elizabeth A Morris,et al.  MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. , 2003, AJR. American journal of roentgenology.

[44]  W. Weber.  PET/MR Imaging: A Critical Appraisal , 2014, The Journal of Nuclear Medicine.

[45]  Jaetae Lee,et al.  Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma. , 2014, Hellenic journal of nuclear medicine.

[46]  Dae Chul Jung,et al.  Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients. , 2009, European journal of cancer.

[47]  J. V. van Meerbeeck,et al.  Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study , 2007, Thorax.

[48]  I. Burger,et al.  PET/MR imaging of bone lesions – implications for PET quantification from imperfect attenuation correction , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[49]  M. Bellomi,et al.  Peritoneal carcinomatosis from ovarian cancer: the role of CT and [18F]FDG-PET/CT , 2010, Abdominal Imaging.

[50]  A. Alavi,et al.  PET/MR imaging: technical aspects and potential clinical applications. , 2013, Radiology.

[51]  S. Ley,et al.  MRI in lung cancer: a pictorial essay. , 2011, The British journal of radiology.

[52]  A. Alavi,et al.  Clinicopathologic factors associated with false negative FDG–PET in primary breast cancer , 2006, Breast Cancer Research and Treatment.

[53]  D. Collins,et al.  Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.

[54]  T. Beyer,et al.  Whole-body PET/MRI: the effect of bone attenuation during MR-based attenuation correction in oncology imaging. , 2014, European journal of radiology.

[55]  F. Zaccagna,et al.  Non-small-cell lung cancer resectability: diagnostic value of PET/MR , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[56]  D Krebs,et al.  Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. , 2000, Radiology.

[57]  D B Plewes,et al.  Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  H. Hricak,et al.  Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. , 2008, Radiology.

[59]  Tatsuya Higashi,et al.  Clinical Value of Image Fusion from MR and PET in Patients with Head and Neck Cancer , 2008, Molecular Imaging and Biology.

[60]  G. Cheon,et al.  Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary Study , 2013, Nuclear Medicine and Molecular Imaging.

[61]  B. I. Choi,et al.  Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. , 1994, Radiology.

[62]  Kyoungjune Pak,et al.  Clinical Implication of PET/MR Imaging in Preoperative Esophageal Cancer Staging: Comparison with PET/CT, Endoscopic Ultrasonography, and CT , 2014, The Journal of Nuclear Medicine.

[63]  R. Birdwell.  Cancer Yield of Mammography, MR, and US in High-Risk Women: Prospective Multi-Institution Breast Cancer Screening Study , 2008 .

[64]  John O. Prior,et al.  Combination of MRI and dynamic FET PET for initial glioma grading , 2014, Nuklearmedizin.

[65]  S. Schoenberg,et al.  Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MRI with a phased-array coil in comparison with pathological findings. , 1998, Journal of computer assisted tomography.

[66]  T. Cheung,et al.  Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. , 2000, AJR. American journal of roentgenology.

[67]  Mitchell D Schnall,et al.  MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. , 2003, Radiology.

[68]  D. Loeffelbein,et al.  Performance of Whole-Body Integrated 18F-FDG PET/MR in Comparison to PET/CT for Evaluation of Malignant Bone Lesions , 2014, The Journal of Nuclear Medicine.

[69]  U. Pietrzyk,et al.  Multi-modality imaging of uveal melanomas using combined PET/CT, high-resolution PET and MR imaging , 2008, Nuklearmedizin.

[70]  J O Barentsz,et al.  Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. , 2001, Journal of the National Cancer Institute.

[71]  Christoph Palm,et al.  Whole-body PET/CT imaging: combining software- and hardware-based co-registration. , 2008, Zeitschrift fur medizinische Physik.

[72]  M. Schwaiger,et al.  Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  M. Viallon,et al.  Whole-Body MRI for Metastases Screening: A Preliminary Study Using 3D VIBE Sequences With Automatic Subtraction Between Noncontrast and Contrast Enhanced Images , 2008, American journal of clinical oncology.

[74]  G. Cheon,et al.  Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous 18F-fluorocholine PET/MRI for primary prostate cancer characterization , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[75]  F. Paparo,et al.  Value of Fused 18F-Choline-PET/MRI to Evaluate Prostate Cancer Relapse in Patients Showing Biochemical Recurrence after EBRT: Preliminary Results , 2014, BioMed research international.

[76]  C. Claussen,et al.  Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study. , 2012, Radiology.

[77]  H. Nakano,et al.  Preoperative CT study of lymph nodes in cervical cancer--its correlation with histological findings. , 1989, Gynecologic oncology.

[78]  M R Segal,et al.  Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. , 1997, JAMA.

[79]  Hyunjin Park,et al.  Detection of Aggressive Primary Prostate Cancer with 11C-Choline PET/CT Using Multimodality Fusion Techniques , 2009, Journal of Nuclear Medicine.

[80]  D. Yousem,et al.  Resectability issues with head and neck cancer. , 2006, AJNR. American journal of neuroradiology.

[81]  M. Senda,et al.  Accuracy of whole-body FDG-PET/CT for detecting brain metastases from non-central nervous system tumors , 2008, Annals of nuclear medicine.

[82]  Osman Ratib,et al.  Potential of hybrid 18F-fluorocholine PET/MRI for prostate cancer imaging , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[83]  D. Kopans,et al.  Invasive Lobular Carcinoma: Spectrum of Enhancement and Morphology on Magnetic Resonance Imaging , 2003, The breast journal.

[84]  E. Pisano,et al.  Should FDG PET be used to decide whether a patient with an abnormal mammogram or breast finding at physical examination should undergo biopsy? , 2002, Academic radiology.

[85]  Felix Nensa,et al.  Depiction and characterization of liver lesions in whole body [¹⁸F]-FDG PET/MRI. , 2013, European journal of radiology.

[86]  Jan Grimm,et al.  Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle , 2014, Nature Communications.

[87]  J. Epstein,et al.  A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score. , 2008, The Journal of urology.

[88]  Sotirios Bisdas,et al.  Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients--current state of image quality. , 2012, European journal of radiology.

[89]  V. Khoo,et al.  Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma , 2014, European Radiology.

[90]  G. Gladish,et al.  Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[91]  J. Czernin,et al.  Does PET/MR Imaging Improve Cancer Assessments? Literature Evidence from More Than 900 Patients , 2014, The Journal of Nuclear Medicine.

[92]  S. Uribe,et al.  Accuracy of imaging methods for detection of bone tissue invasion in patients with oral squamous cell carcinoma. , 2013, Dento maxillo facial radiology.

[93]  A. Sihoe,et al.  Lung cancer staging. , 2004, The Journal of surgical research.

[94]  Gudrun Wagenknecht,et al.  MRI for attenuation correction in PET: methods and challenges , 2012, Magnetic Resonance Materials in Physics, Biology and Medicine.

[95]  S. Matsumoto,et al.  Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients. , 2015, Radiology.

[96]  B. Branstetter,et al.  Indications for PET/CT in the head and neck. , 2008, Otolaryngologic clinics of North America.

[97]  Felix Nensa,et al.  Simultaneous 18F Choline Positron Emission Tomography/Magnetic Resonance Imaging of the Prostate: Initial Results , 2013, Investigative radiology.

[98]  J. Engh,et al.  Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer. , 2013, Neurosurgery.

[99]  H. Zaidi,et al.  An outlook on future design of hybrid PET/MRI systems. , 2011, Medical physics.

[100]  Ernst J Rummeny,et al.  Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. , 2009, European journal of radiology.

[101]  Gerald Q. Maguire,et al.  Role of Fusion of Prone FDG‐PET and Magnetic Resonance Imaging of the Breasts in the Evaluation of Breast Cancer , 2010, The breast journal.

[102]  H. Quick.  Integrated PET/MR , 2014, Journal of magnetic resonance imaging : JMRI.

[103]  Michael Laniado,et al.  PET/MRI in head and neck cancer: initial experience , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[104]  E Grabbe,et al.  Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. , 1999, Radiology.

[105]  Patrick Veit-Haibach,et al.  Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detection , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[106]  C. Gatsonis,et al.  Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. , 2007, Radiology.

[107]  R. Shah,et al.  Introducing Parametric Fusion PET/MRI of Primary Prostate Cancer , 2012, The Journal of Nuclear Medicine.

[108]  Zhang Lin,et al.  Sensitivity of PET/MR images in liver metastases from colorectal carcinoma. , 2011, Hellenic journal of nuclear medicine.

[109]  Sibylle Ziegler,et al.  Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[110]  A. Padhani.  Integrating multiparametric prostate MRI into clinical practice , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

[111]  L. Pina,et al.  18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[112]  M. J. García-Velloso,et al.  Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer , 2006, The British journal of surgery.

[113]  B. Schölkopf,et al.  MR-Based PET attenuation correction for PET/MR imaging. , 2013, Seminars in nuclear medicine.

[114]  G. V. von Schulthess,et al.  Value of Retrospective Fusion of PET and MR Images in Detection of Hepatic Metastases: Comparison with 18F-FDG PET/CT and Gd-EOB-DTPA–Enhanced MRI , 2010, Journal of Nuclear Medicine.

[115]  C. Goldsmith,et al.  A Prospective Evaluation of Positron Emission Tomography Scanning, Sentinel Lymph Node Biopsy, and Standard Axillary Dissection for Axillary Staging in Patients with Early Stage Breast Cancer , 2004, Annals of Surgical Oncology.